An entire issue of the prestigious journal Science on October 1, 2026 was devoted to women's health.
Its stated goal is to address historical underrepresentation of women in clinical trials and close critical knowledge gaps in female biology beyond reproduction.
One review carried a particularly important message that resonated: menopause should be reframed not simply as something to get through, but as an opportunity to support healthy aging.
Menopause is a life stage that virtually every woman will experience if she lives long enough. And its relevance extends well beyond women themselves. If you have a mother, sister, spouse, partner, or daughter, menopause is part of the health story of people you care about.
Menopause Is More Than a Transition
For something so universal, menopause has historically received surprisingly little attention in medical research.
Women may spend roughly 40% of their lives after menopause, while the transition itself can extend over many years. Yet menopause is still often treated primarily as a collection of symptoms rather than as an important period in long-term health.
That perspective is beginning to change.
Researchers increasingly view menopause as a potential inflection point in healthy aging. The age at which menopause occurs, whether it happens naturally or is medically induced, the duration of the transition, and the symptoms a woman experiences can all provide information about future health. These characteristics have been associated with later risks including osteoporosis, metabolic disease, cardiovascular disease, and dementia. Importantly, menopause may carry information about future health even in women who experience few or no obvious symptoms.
This does not mean that menopause causes these conditions. Rather, understanding the biological changes occurring during this period may help researchers and clinicians identify opportunities for prevention, monitoring, and earlier intervention.
Menopause Symptoms Are Real, and They Can Last for Years
The impact of menopause on quality of life can be substantial.
Hot flashes and night sweats, known collectively as vasomotor symptoms, affect the majority of women during the menopausal transition.
But they are only part of the picture. Perhaps most importantly, there is no single menopause experience. The age of onset, symptoms, severity, duration, and biological response vary considerably from one woman to another.
Researchers have documented as many as 72 symptoms associated with menopause, and women on average experience seven symptoms at the same time. Symptoms can persist for years; studies have estimated an average duration of around 7 years.Many of the most commonly reported changes involve the brain and nervous system, including:
- brain fog and difficulty concentrating
- sleep disruption
- changes in mood
- anxiety or irritability
- memory complaints
Menopause Hormone Therapy: Misconceptions and Modern Reevaluation
Menopause hormone therapy, or MHT, uses estrogen and, when appropriate, progestogens to supplement hormones that decline as ovarian function changes. It is now considered a first-line treatment option for menopausal symptoms and the most effective treatment for vasomotor symptoms such as hot flashes and night sweats.
But few areas of women's health have generated as much debate.
Much of the controversy traces back to the Women's Health Initiative, a very large randomized clinical trial launched in the 1990s to examine the health effects of one specific oral synthetic hormone therapy. Findings from that study profoundly influenced medical practice and led many women and clinicians to become cautious about MHT, because in 2002 the study was halted due to increased risk of cancer and blood clots.
One lesson from the research that followed is that "hormone therapy" is not one single treatment.
There are many formulations and approaches. Hormone therapies can differ in:
- the hormones used
- the dose
- whether estrogen is taken orally, through the skin, or locally in the vagina
- the age at which treatment begins
- whether hormones are taken continuously or cyclically
Those differences matter.
The effects, and the balance between potential risks and benefits, can vary according to the type of treatment, route of administration, age at initiation, reproductive history, and an individual's health profile. The U.S. Food and Drug Administration announced the removal of the MHT black box warning in 2025. Yet the misconception persists: it is estimated that less than 2% of women age 40 and older in the US are on MHT.
Research since the Women's Health Initiative has continued to refine our understanding of these differences. Studies generally support benefits of appropriate hormone therapy for menopausal symptoms and bone health, while questions about cardiovascular, cognitive, and other long-term effects depend strongly on the population being studied and the specific treatment being used. There is still much we need to learn. More research is particularly needed on different doses and formulations, including transdermal therapies and low-dose vaginal estrogens, and in younger symptomatic women and more racially and ethnically diverse populations.
Menopause Is Personal
Perhaps the clearest message emerging from modern menopause research is that there is unlikely to be a universal prescription for healthy aging through menopause. Hormones interact with age, genetics, reproductive history, lifestyle, existing health conditions, and social and environmental factors. Two women at the same age can therefore experience menopause very differently and may have very different treatment needs. That makes menopause not simply an endpoint in reproductive life, but an important window into a woman's future health.
Instead of asking only, "How do we manage the symptoms?", researchers are increasingly asking a broader question:
What can menopause teach us about how to help women stay healthier for the decades that follow?
And since at Coprata we care about microbiome function, we wonder: could changes in microbiome function reflect how the body responds to menopause hormone therapy?
References
- Gravelsins LL, Perović M, Alexander MW, Splinter TFL, McGovern AJ, Rabin JS, Galea LAM. Reframing menopause and menopause hormone therapy as opportunities for healthy aging. Science. 2026;394(6819):60-68.
